▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

Steven Herne Joins Unlearn’s Executive Team as Chief Commercial Officer

Unlearn®, a leader in artificial intelligence research in medicine, today announced the appointment of Steve Herne as its first Chief Commercial Officer. Herne will spearhead commercial strategies to...

Business Wire

SAN FRANCISCO: Unlearn®, a leader in artificial intelligence research in medicine, today announced the appointment of Steve Herne as its first Chief Commercial Officer. Herne will spearhead commercial strategies to propel the company’s growth following their successful Series C funding.

"Things continue to move fast at Unlearn, and Steve’s proven track record in healthcare innovation makes him the perfect leader to shape our commercial strategy,” said Charles Fisher, Ph.D., founder and CEO of Unlearn.

Herne, with over 25 years of experience in the pharmaceutical research and development market, has previously led long-term strategic direction as Chief Commercial Officer at WCG and Bioclinica. Herne's impressive career also includes leadership positions at ERT, Icon Development Solutions, Covance, MDS Pharma Services, and Inveresk Research.

"Unlearn is doing what others have tried for years – innovating to overcome some of the biggest bottlenecks in clinical development—that’s what excites me most,” said Herne. “I look forward to driving the adoption of our groundbreaking solutions using digital twins of clinical trial participants in clinical research.”

About Unlearn

Unlearn is a pioneering artificial intelligence research company that is revolutionizing clinical research with computational models of patients called digital twins. Digital twins provide forecasts of an individual’s health outcomes. They are used in Unlearn’s Digital Twins Platform to help pharmaceutical and biotech companies optimize clinical development and quickly and confidently produce trustworthy outcomes. For more information, please visit www.unlearn.ai or follow @UnlearnAI on Twitter/X and @unlearn-ai on LinkedIn.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

ITALIAN PROJECT AWARDS 2023: the best IT projects of the year, awarded

Now in its third edition, the initiative is targeted at the ICT professional world and honours projects based on innovative ideas and technologies, realised…

I3P launches the Cybersecurity Incubation Program

The I3P's initiative is promoted together with the National Cybersecurity Agency in collaboration with Leonardo and C*Sparks.

iVis Technologies enables remotely-controlled corneal telesurgery

It's based on Italian technologies the first successful intercontinental telesurgery intervention for keratoconus carried out remotely, connecting Bari…

Most read

Genesys Recognizes Modivcare as Winner of EX Mobilizer Award

Genesys®, a global cloud leader in AI-powered experience orchestration, announced Modivcare as the winner of the Employee Experience (EX) Mobilizer category…

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

MDS Property Management Software Achieves SOC 2 Compliance

#newyorkcity--MDS Property Management Software is pleased to announce the successful completion of its System and Organization Controls (SOC) 2 audit,…

IP Infusion Hosts the First Telecom Infra Project MANTRA Proof of Concept…

#TIPMANTRA--IP Infusion, a global leader in open networking solutions, has completed the Phase 1 Proof of Concept (PoC) in its lab for the Telecom Infra…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!